 Irvine, CA, April 14, 2021 GLOBE NEWSWIRE -- Odyssey Group International, Inc. OTCQB: ODYY the Company or Odyssey, a technology and asset acquisition company focused on developing unique, life-saving medical products, today announced the formation of a Scientific Advisory Board SAB with the appointment of leading experts in the fields of neurology, cardiology and preclinical drug development. The SAB will guide and advise the Company as it advances its proprietary platforms developing innovative technologies that address unmet medical needs. 